Market Overview:
The global cancer ablation devices market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The market growth is attributed to the increasing incidence of cancer, technological advancements in cancer ablation devices, and rising demand for minimally invasive procedures. Based on type, the global cancer ablation devices market is segmented into cryoablation, high-intensity focused ultrasound (HIFU), laser interstitial thermal therapy (LiTT), microwave ablation (MWA), radiofrequency ablation (RFA), irreversible electroporation (Ire), and non-thermal ablation. Cryoablation held the largest share of the global cancer ablative devices market in 2017 owing to its advantages such as low invasiveness and short treatment time. However, HIFU is expected to grow at a higher CAGR during the forecast period due its ability to target tumors with precision and reduced side effects as compared to other ablative therapies. Based on application, the global cancer ablative devices market is segmented into brain tumor surgery, breast tumor surgery colorectal tumor surgery kidney tumor surgery liver tumor surgery lung tumor surgery pancreatic tumorsurgery prostate tumorsurgery Other applications). Brain Cancer held the largest share of this market in 2017 owingtoits high prevalenceandthe need for effective treatments options.
Product Definition:
A cancer ablation device is a medical device used to treat cancer. It is a type of radiation therapy that uses high-intensity energy beams to kill cancer cells.
Cryoablation:
Cryoablation is a minimally invasive surgical procedure used to remove abnormal tissue. It involves the use of extremely cold temperatures to freeze and kill tissues or cells. The process is useful for treating skin tags, warts, lesions, and other growths that are noncancerous but persistent.
High-Intensity Focused Ultrasound (HIFU):
High-intensity focused ultrasound (HIFU) is a new noninvasive surgical procedure that uses high-frequency sound waves to destroy targeted tissues. The device works by heating the tissue to temperatures as high as 60°C, which leads to coagulation of cells and death. HIFU devices are used for various applications such as treatment of kidney stones, removal of skin tags, and other cosmetic procedures.
Application Insights:
The application segment of the global cancer ablation devices market is categorized into brain cancer, brown fat, colorectal cancer, kidney cancer, liver cancer, lungcancer and others. The other applications include prostate and pancreatic cancers. Prostatecancer dominated the overall application segment in 2017 owing to increasing cases of prostate tumor worldwide. For instance, according to Urologycare Foundation Inc., around 6 million men are diagnosed with prostate tumor every year globally which leads to death of around 200 thousand men due to their disease each year. Thus it can be concluded that increase in incidence rate for various types of cancers is leading towards high demand for ablation devices globally during the forecast period from 2018-2030H1.
Regional Analysis:
North America dominated the global market in 2017 owing to the availability of technologically advanced products, high adoption rate of novel therapies, and a large number of clinical trials. Moreover, an increase in government funding for cancer research is positively influencing the regional growth. For instance, as per NCI fact sheet published in 2018; Cancer Research and Development Foundation has contributed over billion for cancer research from 1982 to 2016. Asia Pacific is expected to witness lucrative growth during the forecast period due to increasing disposable income levels coupled with growing awareness about early diagnosis & treatment options for various cancers.
Key players operating in this space are Stryker Corporation; Medtronic plc.; Boston Scientific Corporation; Intuitive Surgical Inc.; Terumo BCT USA LLC.; Cyberonics LLC; US WorldMed Inc.; Acclarents Ltd., etc.
Growth Factors:
- Increasing incidence of cancer: The increasing incidence of cancer is the major growth driver for the global cancer ablation devices market. According to a study by the World Health Organization (WHO), an estimated 14 million new cases of cancer were diagnosed in 2012, and this number is expected to rise to 24 million by 2030. This growing prevalence of cancer is primarily attributed to the aging population and lifestyle changes.
- Rising demand for minimally invasive procedures: The demand for minimally invasive procedures is rising due to their advantages over traditional surgical procedures, such as shorter hospital stays, reduced pain, and faster recovery times. Cancer ablation devices are increasingly being used for minimally invasive surgeries as they offer several benefits over other treatment options such as chemotherapy or radiation therapy.
- Technological advancements: The technological advancements in cancer ablation devices are aiding in their wider adoption across hospitals and clinics worldwide. These advancements are helping make these devices smaller, more accurate, and easier to use which is resulting in higher patient satisfaction levels post-treatment..
Scope Of The Report
Report Attributes
Report Details
Report Title
Cancer Ablation Devices Market Research Report
By Type
Cryoablation, High-Intensity Focused Ultrasound (HIFU), Laser Interstitial Thermal Therapy (LiTT), Microwave Ablation (MWA), Radiofrequency Ablation (RFA), Irreversible Electroporation (Ire), Non-Thermal Ablation
By Application
Brain Cancer, Brown, Colorectal Cancer, Kidney Cancer, Liver Cancer, Lung Cancer, Pancreatic Cancer, Prostate Cancer
By Companies
Alfresa Pharma Corp., AngioDynamics, Inc., BTG plc (Galil Medical Ltd./Perseon Medical), Biomedical S.r.l., Boston Scientific Corporation, CSA Medical, Inc., Chongqing Haifu Medical Technology Co., Ltd, ECO Medical, EDAP TMS S.A., HS Hospital Service S.p.A., IceCure Medical, Inc., Johnson & Johnson (Ethicon, Inc.), Kang-Yu Medical Co., Ltd., MedLink Technologies LLC, MedWaves, Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
192
Number of Tables & Figures
135
Customization Available
Yes, the report can be customized as per your need.
Global Cancer Ablation Devices Market Report Segments:
The global Cancer Ablation Devices market is segmented on the basis of:
Types
Cryoablation, High-Intensity Focused Ultrasound (HIFU), Laser Interstitial Thermal Therapy (LiTT), Microwave Ablation (MWA), Radiofrequency Ablation (RFA), Irreversible Electroporation (Ire), Non-Thermal Ablation
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Brain Cancer, Brown, Colorectal Cancer, Kidney Cancer, Liver Cancer, Lung Cancer, Pancreatic Cancer, Prostate Cancer
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Alfresa Pharma Corp.
- AngioDynamics, Inc.
- BTG plc (Galil Medical Ltd./Perseon Medical)
- Biomedical S.r.l.
- Boston Scientific Corporation
- CSA Medical, Inc.
- Chongqing Haifu Medical Technology Co., Ltd
- ECO Medical
- EDAP TMS S.A.
- HS Hospital Service S.p.A.
- IceCure Medical, Inc.
- Johnson & Johnson (Ethicon, Inc.)
- Kang-Yu Medical Co., Ltd.
- MedLink Technologies LLC
- MedWaves, Inc.
Highlights of The Cancer Ablation Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Cryoablation
- High-Intensity Focused Ultrasound (HIFU)
- Laser Interstitial Thermal Therapy (LiTT)
- Microwave Ablation (MWA)
- Radiofrequency Ablation (RFA)
- Irreversible Electroporation (Ire)
- Non-Thermal Ablation
- By Application:
- Brain Cancer
- Brown
- Colorectal Cancer
- Kidney Cancer
- Liver Cancer
- Lung Cancer
- Pancreatic Cancer
- Prostate Cancer
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cancer Ablation Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cancer ablation devices are medical devices that use heat and radiation to destroy cancer cells.
Some of the major companies in the cancer ablation devices market are Alfresa Pharma Corp., AngioDynamics, Inc., BTG plc (Galil Medical Ltd./Perseon Medical), Biomedical S.r.l., Boston Scientific Corporation, CSA Medical, Inc., Chongqing Haifu Medical Technology Co., Ltd, ECO Medical, EDAP TMS S.A., HS Hospital Service S.p.A., IceCure Medical, Inc., Johnson & Johnson (Ethicon, Inc.), Kang-Yu Medical Co., Ltd., MedLink Technologies LLC, MedWaves, Inc..
The cancer ablation devices market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cancer Ablation Devices Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cancer Ablation Devices Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cancer Ablation Devices Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cancer Ablation Devices Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cancer Ablation Devices Market Size & Forecast, 2018-2028
4.5.1 Cancer Ablation Devices Market Size and Y-o-Y Growth
4.5.2 Cancer Ablation Devices Market Absolute $ Opportunity
Chapter 5 Global Cancer Ablation Devices Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Cancer Ablation Devices Market Size Forecast by Type
5.2.1 Cryoablation
5.2.2 High-Intensity Focused Ultrasound (HIFU)
5.2.3 Laser Interstitial Thermal Therapy (LiTT)
5.2.4 Microwave Ablation (MWA)
5.2.5 Radiofrequency Ablation (RFA)
5.2.6 Irreversible Electroporation (Ire)
5.2.7 Non-Thermal Ablation
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Cancer Ablation Devices Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Cancer Ablation Devices Market Size Forecast by Applications
6.2.1 Brain Cancer
6.2.2 Brown
6.2.3 Colorectal Cancer
6.2.4 Kidney Cancer
6.2.5 Liver Cancer
6.2.6 Lung Cancer
6.2.7 Pancreatic Cancer
6.2.8 Prostate Cancer
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cancer Ablation Devices Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cancer Ablation Devices Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Cancer Ablation Devices Analysis and Forecast
9.1 Introduction
9.2 North America Cancer Ablation Devices Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Cancer Ablation Devices Market Size Forecast by Type
9.6.1 Cryoablation
9.6.2 High-Intensity Focused Ultrasound (HIFU)
9.6.3 Laser Interstitial Thermal Therapy (LiTT)
9.6.4 Microwave Ablation (MWA)
9.6.5 Radiofrequency Ablation (RFA)
9.6.6 Irreversible Electroporation (Ire)
9.6.7 Non-Thermal Ablation
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Cancer Ablation Devices Market Size Forecast by Applications
9.10.1 Brain Cancer
9.10.2 Brown
9.10.3 Colorectal Cancer
9.10.4 Kidney Cancer
9.10.5 Liver Cancer
9.10.6 Lung Cancer
9.10.7 Pancreatic Cancer
9.10.8 Prostate Cancer
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Cancer Ablation Devices Analysis and Forecast
10.1 Introduction
10.2 Europe Cancer Ablation Devices Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Cancer Ablation Devices Market Size Forecast by Type
10.6.1 Cryoablation
10.6.2 High-Intensity Focused Ultrasound (HIFU)
10.6.3 Laser Interstitial Thermal Therapy (LiTT)
10.6.4 Microwave Ablation (MWA)
10.6.5 Radiofrequency Ablation (RFA)
10.6.6 Irreversible Electroporation (Ire)
10.6.7 Non-Thermal Ablation
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Cancer Ablation Devices Market Size Forecast by Applications
10.10.1 Brain Cancer
10.10.2 Brown
10.10.3 Colorectal Cancer
10.10.4 Kidney Cancer
10.10.5 Liver Cancer
10.10.6 Lung Cancer
10.10.7 Pancreatic Cancer
10.10.8 Prostate Cancer
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Cancer Ablation Devices Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Cancer Ablation Devices Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Cancer Ablation Devices Market Size Forecast by Type
11.6.1 Cryoablation
11.6.2 High-Intensity Focused Ultrasound (HIFU)
11.6.3 Laser Interstitial Thermal Therapy (LiTT)
11.6.4 Microwave Ablation (MWA)
11.6.5 Radiofrequency Ablation (RFA)
11.6.6 Irreversible Electroporation (Ire)
11.6.7 Non-Thermal Ablation
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Cancer Ablation Devices Market Size Forecast by Applications
11.10.1 Brain Cancer
11.10.2 Brown
11.10.3 Colorectal Cancer
11.10.4 Kidney Cancer
11.10.5 Liver Cancer
11.10.6 Lung Cancer
11.10.7 Pancreatic Cancer
11.10.8 Prostate Cancer
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Cancer Ablation Devices Analysis and Forecast
12.1 Introduction
12.2 Latin America Cancer Ablation Devices Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Cancer Ablation Devices Market Size Forecast by Type
12.6.1 Cryoablation
12.6.2 High-Intensity Focused Ultrasound (HIFU)
12.6.3 Laser Interstitial Thermal Therapy (LiTT)
12.6.4 Microwave Ablation (MWA)
12.6.5 Radiofrequency Ablation (RFA)
12.6.6 Irreversible Electroporation (Ire)
12.6.7 Non-Thermal Ablation
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Cancer Ablation Devices Market Size Forecast by Applications
12.10.1 Brain Cancer
12.10.2 Brown
12.10.3 Colorectal Cancer
12.10.4 Kidney Cancer
12.10.5 Liver Cancer
12.10.6 Lung Cancer
12.10.7 Pancreatic Cancer
12.10.8 Prostate Cancer
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Cancer Ablation Devices Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Cancer Ablation Devices Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Cancer Ablation Devices Market Size Forecast by Type
13.6.1 Cryoablation
13.6.2 High-Intensity Focused Ultrasound (HIFU)
13.6.3 Laser Interstitial Thermal Therapy (LiTT)
13.6.4 Microwave Ablation (MWA)
13.6.5 Radiofrequency Ablation (RFA)
13.6.6 Irreversible Electroporation (Ire)
13.6.7 Non-Thermal Ablation
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Cancer Ablation Devices Market Size Forecast by Applications
13.10.1 Brain Cancer
13.10.2 Brown
13.10.3 Colorectal Cancer
13.10.4 Kidney Cancer
13.10.5 Liver Cancer
13.10.6 Lung Cancer
13.10.7 Pancreatic Cancer
13.10.8 Prostate Cancer
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cancer Ablation Devices Market: Competitive Dashboard
14.2 Global Cancer Ablation Devices Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Alfresa Pharma Corp.
14.3.2 AngioDynamics, Inc.
14.3.3 BTG plc (Galil Medical Ltd./Perseon Medical)
14.3.4 Biomedical S.r.l.
14.3.5 Boston Scientific Corporation
14.3.6 CSA Medical, Inc.
14.3.7 Chongqing Haifu Medical Technology Co., Ltd
14.3.8 ECO Medical
14.3.9 EDAP TMS S.A.
14.3.10 HS Hospital Service S.p.A.
14.3.11 IceCure Medical, Inc.
14.3.12 Johnson & Johnson (Ethicon, Inc.)
14.3.13 Kang-Yu Medical Co., Ltd.
14.3.14 MedLink Technologies LLC
14.3.15 MedWaves, Inc.
